| Holly Clare Simpson, MD | |
|
795 E Marshall St, Ste 103, West Chester, PA 19380-4400 | |
| (610) 429-3004 | |
| Not Available |
| Full Name | Holly Clare Simpson |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 16 Years |
| Location | 795 E Marshall St, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437310331 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD454053 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mudgil Eye Associates Pc | 1052302478 | 3 |
| Wills Eye Ophthalmology Clinic, Inc | 9133025166 | 129 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
Deaf infants who have been exposed to American Sign Language are better at following an adult's gaze than their hearing peers, supporting the idea that social-cognitive development is sensitive to different kinds of life experiences.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 9 days ago
| Entity Name | Wills Eye Ophthalmology Clinic, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184624009 PECOS PAC ID: 9133025166 Enrollment ID: O20031210000801 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
Deaf infants who have been exposed to American Sign Language are better at following an adult's gaze than their hearing peers, supporting the idea that social-cognitive development is sensitive to different kinds of life experiences.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 9 days ago
| Entity Name | Mudgil Eye Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811008972 PECOS PAC ID: 1052302478 Enrollment ID: O20050420000611 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
Deaf infants who have been exposed to American Sign Language are better at following an adult's gaze than their hearing peers, supporting the idea that social-cognitive development is sensitive to different kinds of life experiences.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Holly Clare Simpson, MD 795 E Marshall St, Ste 103, West Chester, PA 19380-4400 Ph: (610) 429-3004 | Holly Clare Simpson, MD 795 E Marshall St, Ste 103, West Chester, PA 19380-4400 Ph: (610) 429-3004 |
News Archive
A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
Deaf infants who have been exposed to American Sign Language are better at following an adult's gaze than their hearing peers, supporting the idea that social-cognitive development is sensitive to different kinds of life experiences.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 9 days ago
Robert P Liss, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 915 Old Fern Hill Rd, Building B Ste 200, West Chester, PA 19380 Phone: 610-696-1230 Fax: 610-918-0803 | |
Samantha Lynn Marek, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 915 Old Fern Hill Rd Ste 200, West Chester, PA 19380 Phone: 610-696-1230 | |
Dr. Gregory Warren Oldham, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd Bldg B Ste 200, West Chester, PA 19380 Phone: 610-696-1230 Fax: 610-696-2341 | |
Dr. Cyrus Louis Mineo, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1410 Carroll Brown Way, West Chester, PA 19382 Phone: 215-275-4197 | |
Dr. Richard B Kent, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 845 W Chester Pike, West Chester, PA 19382 Phone: 610-692-8100 Fax: 610-436-4011 | |
Dr. Michael Joseph Ward Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd Bldg B Ste 200, West Chester, PA 19380 Phone: 610-696-1230 Fax: 610-696-2341 |